Carbostyril Derivatives Including Cilostazol for Treating Fatty Liver

Abstract

The invention relates to a medicament for preventing and/or treating fatty liver which comprises as an active ingredient cilostazol or a pharmaceutically acceptable salt thereof.

1 .- 4 . (canceled) 
     
     
         5 . A method for preventing and/or treating fatty liver which comprises administering as an active ingredient an effective amount of a carbostyril derivative or a salt of the following formula to a patient in need thereof: 
       
         
           
           
               
               
           
         
       
       wherein A is a lower alkylene group, R is a cycloalkyl group, the bonding between 3- and 4-positions of the carbostyril skeleton is a single bond or a double bond. 
     
     
         6 . The method of  claim 5  wherein the active ingredient is 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]3,4-dihydro- carbostyril  or a salt thereof.